Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
Omega Life Science has developed an aerosol drug-delivery system for systemic, local, and CNS targeting. The system consists of a proprietary inhaler and a tailor-made formulation technology.
The companys aerosolization technology has enabled development of a proprietary inhaler platform, Alphazer, for producing aerosols with parameters leading to improved patient experience and enhanced therapeutic effect.
The Alphazer is an inhaler platform that produces submicron- to micron-sized droplets and submicron- to nano-sized dry particles of the desired pharmaceutical compound. The inhaler is a handheld device that is distributed with proprietary disposable drug cartridges.
Omega Life Science is a subsidiary of Nanosol Ltd.